Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.47 |
| ▸ | MME | P08473 | 4/20 | 0.46 |
| ▸ | LAP3 | P28838 | 3/20 | 0.44 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.43 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.43 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.42 |
| ▸ | PLA2G5 | P39877 | 2/20 | 0.42 |
| ▸ | GRN | P28799 | 1/20 | 0.42 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.42 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7563707 | 1.00 | ALDH1A1 (0.57) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL24119241 | 0.84 | ALDH1A1 (0.55) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL6374257 | 0.83 | ALDH1A1 (0.53) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL596517 | 0.83 | ALDH1A1 (0.59) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL6010360 | 0.82 | ALDH1A1 (0.48) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL6010370 | 0.82 | ALDH1A1 (0.48) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL7916647 | 0.82 | ALDH1A1 (0.47) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL73762 | 0.82 | MAPT (0.60) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL839404 | 0.82 | ALDH1A1 (0.59) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL3451868 | 0.82 | ALDH1A1 (0.59) | ALDH1A1MEN1LMNAKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0792146-A1 | INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES | HEMASURE, INC. (US) | 1997-09-03 | — | — | EP | claimed |
| WO-1997002028-A1 | INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES | HEMASURE, INC. (US) | 1997-01-23 | — | — | WO | claimed |
| CN-105169369-B | Treat and prevent the method and pharmaceutical composition of hepatitis C infection | 中美华世通生物医药科技（武汉）有限公司 | 2019-10-18 | — | — | CN | disclosed |
| WO-2010046713-A2 | METHODS FOR PREPARING HETEROCYCLIC RINGS | ISIS INNOVATION (GB) | 2010-04-29 | — | — | WO | disclosed |
| EP-1229889-A1 | USE OF A NONIMMUNOSUPPRESSIVE CYCLOSPORIN A DERIVATIVE FOR HAIR GROWTH | LG Household & Health Care Ltd. (KR) | 2002-08-14 | — | — | EP | disclosed |
| WO-2001035913-A1 | USE OF A NONIMMUNOSUPPRESSIVE CYCLOSPORIN A DERIVATIVE FOR HAIR GROWTH | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2001-05-25 | — | — | WO | disclosed |
| EP-0792146-A1 | INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES | HEMASURE, INC. (US) | 1997-09-03 | — | — | EP | disclosed |
| WO-1997002028-A1 | INACTIVATION OF PATHOGENS USING HYDROXYMETHYLAMINES | HEMASURE, INC. (US) | 1997-01-23 | — | — | WO | disclosed |
| EP-0606295-A1 | TETRAPHENYLPORPHYN DERIVATIVES | SANDOZ-ERFINDUNGEN Verwaltungsgesellschaft m.b.H. (AT) | 1994-07-20 | — | — | EP | disclosed |